62 related articles for article (PubMed ID: 12835816)
1. [Assesing the GRDOSIS Software program as a tool to analyse drug usase by DRGs].
Alerany Pardo C; Blanco Serrano B; Estaún Díaz E; López Briz E; Monterde Junyent J; Montero Pardillo M; Montojo Guillén C; Montoro Ronsano JB; Moriel Sánchez MC; Napal Lecumberri V; Vilaseca Tomás A
Farm Hosp; 2003; 27(3):150-8. PubMed ID: 12835816
[TBL] [Abstract][Full Text] [Related]
2. Analyzing pharmacy charges using DRGs.
Catania HF; Ibrahim OM; Guasco SL; Catania PN
Am J Hosp Pharm; 1984 May; 41(5):920-3. PubMed ID: 6428225
[TBL] [Abstract][Full Text] [Related]
3. Clinical redesign using all patient refined diagnosis related groups.
Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA
Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092
[TBL] [Abstract][Full Text] [Related]
4. [Evaluating the first German diagnosis-related groups (G-DRG) in cardiological patients: problems in the correct medical and economic grouping].
Reinecke H; Bunzemeier H; Fürstenberg T; Rothenburger M; Böcker D; Scheld HH; Breithardt G; Roeder N
Z Kardiol; 2003 Jul; 92(7):581-94. PubMed ID: 12883843
[TBL] [Abstract][Full Text] [Related]
5. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
[TBL] [Abstract][Full Text] [Related]
6. Identification of drug costs within diagnosis related groups.
Kolar R; Stanaszek W; Osborne J; Dougherty K
Hosp Pharm; 1984 Nov; 19(11):731-5. PubMed ID: 10310864
[TBL] [Abstract][Full Text] [Related]
7. Development of lengths of stay and DRG cost weights in dermatology from 2003 to 2006.
Wenke A; Müller ML; Babapirali J; Rompel R; Hensen P
J Dtsch Dermatol Ges; 2009 Aug; 7(8):680-7. PubMed ID: 19250249
[TBL] [Abstract][Full Text] [Related]
8. [Inpatient treatment costs of skin diseases. Diagnosis-based cost calculation in a university dermatology clinic].
Richert L; Weber R; Doelfs P; Tscheulin D; Augustin M
Hautarzt; 2004 Nov; 55(11):1047-51. PubMed ID: 15448929
[TBL] [Abstract][Full Text] [Related]
9. Describing Iranian hospital activity using Australian Refined DRGs: a case study of the Iranian Social Security Organisation.
Ghaffari S; Jackson TJ; Doran CM; Wilson A; Aisbett C
Health Policy; 2008 Jul; 87(1):63-71. PubMed ID: 17980930
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and economic analysis of an internal medicine-infectious disease department at a university general hospital (2005-2006)].
Gómez J; García-Vázquez E; Antonio Puertas J; Ródenas J; Herrero JA; Albaladejo C; Baños V; Canteras M; Alcaraz M
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):70-4. PubMed ID: 19254637
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of flat-rate payment in radiation oncology. German experience with disease-related groups for inpatient funding in radiation oncology].
Glocker S; Loskamp N; Bamberg M; Roeder N
Strahlenther Onkol; 2006 Jun; 182(6):305-11. PubMed ID: 16703284
[TBL] [Abstract][Full Text] [Related]
12. [How does the German DRG system differentiate and reimburse vitreoretinal surgery in diabetic patients?].
Krause M; Goldschmidt AJ; Berg M; Kropf S; Sachs A; Gatzioufas Z; Brückner K; Seitz B
Klin Monbl Augenheilkd; 2008 Oct; 225(10):880-7. PubMed ID: 18951309
[TBL] [Abstract][Full Text] [Related]
13. Data-based pharmacy utilization review identifies those at-risk, improves care, cuts utilization.
Data Strateg Benchmarks; 1998 May; 2(5):74-6. PubMed ID: 10345375
[TBL] [Abstract][Full Text] [Related]
14. Developing drug-use indicators with a computerized drug database and a personal computer software package.
Stolar MH
Am J Hosp Pharm; 1987 May; 44(5):1075-86. PubMed ID: 3605117
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cost accounting methods from different DRG systems and their effect on health care quality.
Leister JE; Stausberg J
Health Policy; 2005 Sep; 74(1):46-55. PubMed ID: 16098411
[TBL] [Abstract][Full Text] [Related]
16. Thoracic aortic aneurysm repair. Direct hospital cost and Diagnosis Related Group reimbursement.
Mishra V; Geiran O; Krohg-Sørensen K; Andresen S
Scand Cardiovasc J; 2008 Feb; 42(1):77-84. PubMed ID: 18273734
[TBL] [Abstract][Full Text] [Related]
17. [The ICD9-ICD9 CM coding system: what is the variance of DRG classification in cardiology?].
Tasso S
G Ital Cardiol; 1997 Nov; 27(11):1175-80. PubMed ID: 9463062
[TBL] [Abstract][Full Text] [Related]
18. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
[TBL] [Abstract][Full Text] [Related]
19. The significance of laboratory testing for the German diagnosis-related group system--the systematic evaluation of comorbidities of relevance to case reimbursement and continued development of the DRG Watchdog software.
Hoffmann GE; Schenker M; Kammann M; Meyer-Lüerssen D; Wilke MH
Clin Lab; 2004; 50(9-10):599-607. PubMed ID: 15481636
[TBL] [Abstract][Full Text] [Related]
20. Estimating the costs of drug-related hospital separations in Australia.
Riddell S; Shanahan M; Degenhardt L; Roxburgh A
Aust N Z J Public Health; 2008 Apr; 32(2):156-61. PubMed ID: 18412687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
